Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel Protease Inhibitors.

Peter Norman

    Drug News & Perspectives
    |April 5, 2003
    PubMed
    Summary
    This summary is machine-generated.

    The Proteinase 2002 symposium highlighted X-ray crystallography as a key tool for designing improved protease inhibitors. Novel inhibitors for serine and cysteine proteases were a major focus for scientists.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The lived experience of depression: a bottom-up review co-written by experts by experience and academics.

    World psychiatry : official journal of the World Psychiatric Association (WPA)·2023
    Same author

    Brexit and UK market exclusivities.

    Pharmaceutical patent analyst·2018
    Same author

    Humira<sup>®</sup>: recent developments.

    Pharmaceutical patent analyst·2017
    Same author

    Enbrel and etanercept biosimilars: a tale of two patent systems.

    Pharmaceutical patent analyst·2017
    Same author

    Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.

    Expert opinion on investigational drugs·2016
    Same author

    Humira: the impending patent battles over adalimumab biosimilars.

    Pharmaceutical patent analyst·2016
    Same journal

    New drug discovery and development in India.

    Drug news & perspectives·2013
    Same journal

    Are we living in the end of the blockbuster drug era?

    Drug news & perspectives·2010
    Same journal

    Molecule of the Month. TAK-875.

    Drug news & perspectives·2010
    Same journal

    Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

    Drug news & perspectives·2010
    Same journal

    Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

    Drug news & perspectives·2010
    Same journal

    Trioxaquines: hybrid molecules for the treatment of malaria.

    Drug news & perspectives·2010
    See all related articles

    Area of Science:

    • Biochemistry
    • Medicinal Chemistry
    • Structural Biology

    Background:

    • The Third RSC-SCI Symposium on Proteinase Inhibitor Design (Proteinase 2002) convened approximately 140 scientists.
    • The symposium focused on advancements in proteinase inhibitor design, a critical area in drug discovery and development.

    Purpose of the Study:

    • To discuss the latest developments in proteinase inhibitor design.
    • To showcase novel compounds and strategies for inhibiting proteases.
    • To emphasize the role of structural biology in inhibitor development.

    Main Methods:

    • Presentations by 17 speakers covered various aspects of proteinase inhibitor design.
    • Emphasis was placed on utilizing X-ray crystallography of enzyme-inhibitor complexes.
    • Discussions included the development of novel inhibitors targeting serine and cysteine proteases.

    Related Experiment Videos

    Main Results:

    • Significant emphasis was placed on X-ray crystallography as an integral tool for designing improved protease inhibitors.
    • The meeting served as a platform for disclosing new chemical compounds.
    • Novel inhibitors targeting serine or cysteine proteases were a key focus of the presentations.

    Conclusions:

    • X-ray crystallography is a vital technique for the rational design of effective protease inhibitors.
    • The symposium successfully facilitated the exchange of new findings in proteinase inhibitor research.
    • The ongoing development of novel inhibitors for serine and cysteine proteases remains a critical area of scientific interest.